Guidelines for ATC classification and DDD assignment - WHOCC

J01MA Fluoroquinolones
Flumequine is classified in J01MB.
The DDDs for the fluoroquinolones are mainly based on the
treatment of respiratory tract infections.
The DDDs for pefloxacin, enoxacin and norfloxacin are based on
the treatment of complicated urinary tract infections.
J01MB Other quinolones
Preparations, which in addition contain a urine acidifier, such as vitamin
C, calcium- or ammonium chloride, are classified at the plain 5th levels.
The DDDs are generally based on the treatment of acute urinary tract
infections. The DDD for rosoxacin is based on single dose
treatment of gonorrhoea.
J01R COMBINATIONS OF ANTIBACTERIALS
This group comprises combinations of two or more antibacterials for
systemic use from different ATC 3rd levels.
J01RA Combinations of antibacterials
Combinations of urinary antiseptics and antiinfectives are classified in
J01RA02.
J01X OTHER ANTIBACTERIALS
This group comprises antibacterials with various modes of action not
classified in the preceding groups.
J01XA Glycopeptide antibacterials
This group comprises glycopeptide antibacterials, inhibiting the cell wall
synthesis of gram positive bacteria. Teicoplanin and intravenous
preparations of vancomycin are classified in this group. Oral
formulations containing vancomycin are classified in A07A.
173